Method for enzymatic synthesis of brivaracetam chiral intermediate
AssigneeZhejiang University of Technology
InventorsRenchao ZHENG, Yuguo ZHENG, Kan ZHAN, Zheming WU
Life of this patent
Estimating the term…
Loading patent…
AssigneeZhejiang University of Technology
InventorsRenchao ZHENG, Yuguo ZHENG, Kan ZHAN, Zheming WU
Estimating the term…
A method for synthesizing a brivaracetam chiral intermediate (R)-3-cyanohexanoic acid by catalyzing the hydrolysis of 3-cyanohexanitile using an enzyme with nitile hydrolysis activity, and the enzyme with nitrile hydrolysis activity is obtained by carrying out a single mutation or a double mutation on an amino acid at position 140 or an amino acid at position 175 in an amino acid sequence as set forth in SEQ ID NO.2. Compared with a wild type, the nitrilase mutant has the activity increased by 10 times, an ee value increased to 300 or more from 39, a substrate conversion rate of 45%, and a product ee which can reach 98.5%, and the yield of (R)-3-aminomethyl-hexanoic acid by catalytic hydrogenation synthesis using (R)-3-cyanohexanoic acid reaches 85% or more. This features a short synthesis route, mild reaction conditions, and high atom economy, and can be applied to the industrial synthesis of the brivaracetam intermediate.
A method for enzymatic synthesis of a brivaracetam chiral intermediate, which is characterized in that the method is a method for synthesizing a brivaracetam chiral intermediate (R)-3-cyanohexanoic acid by using an enzyme with nitrilase activity to catalyze the hydrolysis of 3-cyanohexanenitrile.
Dependencies are inferred from the claim text.